{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:10:11Z","timestamp":1793293811589,"version":"4.5.0"},"reference-count":26,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Background: The most important series devoted to antithyroid drug-induced severe neutropenia and agranulocytosis are Japanese studies, almost specifically in relation to the intake of methimazole. The clinical data of 30 Caucasian patients followed up for antithyroid drug-induced neutropenia at a third-level hospital are reported. Methods: The data of 30 patients with idiosyncratic antithyroid drug-induced neutropenia and agranulocytosis from a cohort study on drug-induced neutropenia and agranulocytosis conducted at the University Hospital of Strasbourg (France) were retrospectively reviewed. Results: The mean patient age was 61.7 years old (range: 20\u201387), and the gender ratio (F\/M) was 4. Several comorbidities were reported in 23 patients (76.7%), with the mean Charlson comorbidity index of 1. The causative drugs were carbimazole and benzylthiouracil, in 28 (93.3%) and 2 cases, respectively, prescribed primarily for multi-hetero-nodular goiter or thyroid nodule to 18 patients (60%). Sore throat and acute tonsillitis (40%), isolated fever (20%), septicemia (13.3%), documented pneumonia (6.7%), and septic shock (6.7%) were the main clinical features upon admission. The mean neutrophil count at nadir was 0.02 and 0 \u00d7 109\/L (range: 0\u20130.3). Regarding the patients\u2019 hospital course: 13 cases (43.3%) worsened during hospitalization, severe sepsis was found in 26.7%, systemic inflammatory response syndrome\u2014in 13.3%, and septic shock\u2014in 3.3% of the cases, respectively. Broad-spectrum antibiotics were indicated for all the patients, and 21 (73.3%) of them received hematopoietic growth factors. Hematological recovery (neutrophil count \u2265 1.5 \u00d7 109\/L) was seen at 8.3 days (range: 2\u201324), but faster in those receiving hematopoietic growth factors (4.9 days, p = 0.046). Two patients died during hospitalization, and the rest had a favorable clinical outcome. Conclusions: Antithyroid drug-induced neutropenia represents a serious complication resulting from the rates of severe infections especially in those cases severe neutropenia. In this setting, an established procedure for the management of patients seems useful or even indispensable in view of potential mortality.<\/jats:p>","DOI":"10.3390\/medicines7030015","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T07:29:07Z","timestamp":1584689347000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7914-7616","authenticated-orcid":false,"given":"Emmanuel","family":"Andr\u00e8s","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Lorenzo-Villalba","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Mourot-Cottet","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Maloisel","sequence":"additional","affiliation":[{"name":"Onco-Hematology, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Tebacher","sequence":"additional","affiliation":[{"name":"Regional Pharmacovigilance Centre of Alsace, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[{"name":"Rheumatology, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Goichot","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Herbrecht","sequence":"additional","affiliation":[{"name":"Onco-Hematology, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar-Ahmad","family":"Zulfiqar","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Strasbourg University Hospitals, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40268-017-0172-1","article-title":"Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management","volume":"17","author":"Vicente","year":"2017","journal-title":"Drugs R&D"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1210\/jc.2011-2221","article-title":"Antithyroid drug-induced hematopoietic damage: A retrospective cohort study of agranulocytosis and pancytopenia involving 50, 385 patients with Graves\u2019 disease","volume":"97","author":"Watanabe","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1989.tb01424.x","article-title":"Methimazole-induced agranulocytosis in Japanese patients with Graves\u2019 disease","volume":"30","author":"Tamai","year":"1989","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2004.02135.x","article-title":"Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK","volume":"61","author":"Pearce","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0953-6205(02)00085-7","article-title":"Modern management of non-chemotherapy drug-induced agranulocytosis: A monocentric cohort study of 90 cases and review of the literature","volume":"13","author":"Maloisel","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/ehm.11.12","article-title":"Clinical presentation and management of drug-induced agranulocytosis","volume":"4","author":"Zimmer","year":"2011","journal-title":"Expert Rev. Hematol."},{"key":"ref_8","first-page":"257","article-title":"Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: Report of an international consensus meeting","volume":"33","year":"1993","journal-title":"Nouvelle Revue Francaise D\u2019hematologie"},{"key":"ref_9","first-page":"171","article-title":"Imputabilit\u00e9 en pharmacovigilance: De la m\u00e9thode fran\u00e7aise originelle aux m\u00e9thodes r\u00e9actualis\u00e9es","volume":"71","author":"Haramburu","year":"2016","journal-title":"Th\u00e9rapie"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.297.6643.262","article-title":"IAAAS: International Agranulocytosis and Aplastic Anaemia Study. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs","volume":"297","author":"Retsagi","year":"1988","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Non-chemotherapy drug-induced agranulocytosis: A systematic review of case reports","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_12","first-page":"299","article-title":"Idiosyncratic drug-induced neutropenia & agranulocytosis","volume":"110","author":"Maloisel","year":"2017","journal-title":"QJM"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1016\/j.revmed.2009.10.067","article-title":"Agranulocytose aux antithyro\u00efdiens de synth\u00e8se: Donn\u00e9es \u00e9pid\u00e9miologiques et cliniques. Etude de 203 cas issus de la base nationale de pharmacovigilance","volume":"30","author":"Weitten","year":"2009","journal-title":"Rev. Med. Interne"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000448586","article-title":"Periodic granulocyte count measuring is useful for detecting asymptomatic agranulocytosis in antithyroid drug-treated patients with Graves\u2019 disease","volume":"5","author":"Nakamura","year":"2016","journal-title":"Eur. Thyroid J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","article-title":"Drug-induced agranulocytosis: Prognostic factors in a serie of 168 episodes","volume":"79","author":"Julia","year":"1991","journal-title":"Br. J. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1742-1241.1988.tb08632.x","article-title":"Recurrent agranulocytosis following carbimazole and propylthiouracil therapy","volume":"42","author":"Ostlere","year":"1988","journal-title":"Br. J. Clin. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose","volume":"98","author":"Cooper","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/thy.2005.15.292","article-title":"Antithyroid drug-induced agranulocytosis: How has granulocyte colony-stimulating factor changed therapy?","volume":"15","author":"Tajiri","year":"2005","journal-title":"Thyroid"},{"key":"ref_19","first-page":"470","article-title":"Prognostic factors of hematological recovery in nonchemotherapy drug-induced agranulocytosis","volume":"88","author":"Maloisel","year":"2003","journal-title":"Haematologica"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03344959","article-title":"Antithyroid drug-induced agranulocytosis: Clinical experience with ten patients treated at one institution and review of the literature","volume":"17","author":"Benker","year":"1994","journal-title":"J. Endocrinol. Invest."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.1996.tb01638.x","article-title":"Drug-related blood dyscrasias","volume":"60","author":"Young","year":"1996","journal-title":"Eur. J. Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1530\/EC-17-0025","article-title":"Rescue pre-operative treatment with Lugol\u2019s solution in uncontrolled Graves\u2019 disease","volume":"6","author":"Calissendorff","year":"2017","journal-title":"Endocr. Connect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/qjmed\/94.8.423","article-title":"The use of haematopoietic growth factors in antithyroid-related drug-induced agranulocytosis: A report of 20 patients","volume":"94","author":"Kurtz","year":"2001","journal-title":"QJM"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1999.9.29","article-title":"Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: A prospective study","volume":"9","author":"Fukata","year":"1999","journal-title":"Thyroid"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.revmed.2016.02.014","article-title":"Agranulocytose aux antithyro\u00efdiens de synth\u00e8se: Revue de la litt\u00e9rature","volume":"37","author":"Weitten","year":"2016","journal-title":"Rev. Med. Interne"}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/3\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:09:54Z","timestamp":1760173794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/3\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["medicines7030015"],"URL":"https:\/\/doi.org\/10.3390\/medicines7030015","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]}}}